Natural Diterpene Carrier-Free Hydrogel Enhances Antigen Presentation and Intensifies T Cell Activation for Tumor Immunotherapy

Xiang Zhang,Luping Yang,Wenmin Pi,Linying Wu,Yisong Shu,Yihang Zhao,Shan Lu,Bo Wang,Jihui Lu,Zhijia Wang,Yaozhi Zhang,Shuchang Yao,Xuemei Huang,Chenze Zhang,Haimin Lei,Penglong Wang

DOI: https://doi.org/10.1016/j.cej.2024.156383

IF: 15.1

2024-01-01

Chemical Engineering Journal

Abstract:Although immunotherapy has revolutionized cancer treatment, the low immunogenicity, insufficient T cells intratumoral infiltration and defective antigen presentation in the "cold" tumor microenvironment limit its clinical application. To address this challenge, enlightened by the clinical combined application of antitumor herb medicines, we developed a carrier-free hydrogel KEEM by integrating multiple natural active lipophilic components with manganese ions into a natural co-assembled ternary system. The KEEM hydrogel induced the formation of hydroxyl radicals by Fenton-like reactions, leading to apoptosis, while simultaneously inducing tumor cell ferroptosis through the system x(c)(-)-GSH-GPX4 axis. Subsequent release of damage-associated molecular patterns (DAMPs) proved the emergence of immunogenic cell death (ICD). Additionally, manganese ions could directly activate the cGAS-STING pathway, further amplifying the immunostimulatory effects. This synergistic effect promoted dendritic cell maturation thus enhancing antigen presentation, and mediating the change of tumor microenvironment (TME) from "cold" to "hot". In hepatoma ascites and melanoma models, KEEM combined with immune checkpoint blockade and adoptive T cell therapy respectively demonstrated promising antitumor effects in vivo, meanwhile showing excellent biocompatibility and biosafety. Thus, the combination of this multi-diterpenoids carrier-free hydrogel with immunotherapy offers a new strategy for clinical immunerefractory tumor treatment.